Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
1,615
+12
+0.7% +$1.41K 0.08% 84
2026
Q1
$193K Buy
1,603
+12
+0.8% +$1.39K 0.09% 75
2025
Q4
$167K Buy
1,591
+14
+0.9% +$1.31K 0.08% 73
2025
Q3
$132K Buy
+1,577
New +$130K 0.07% 79
2024
Q4
Sell
-2,055
Closed -$233K 58
2024
Q3
$233K Buy
+2,055
New +$244K 0.2% 50

Other funds holding MRK

GGM Financials's MRK Position: Q2 2026 in Review

GGM Financials increased its Merck (MRK) stake by 0.75% in Q2 2026, buying an estimated $1.41K and bringing the position to 1,615 shares worth $207K. The position accounts for 0.08% of the portfolio, ranked #84.

GGM Financials first reported a position in MRK in Q3 2024 and has held it in 5 quarters since. The position peaked at $233K in Q3 2024. 1,170 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • GGM Financials held 1,615 shares of Merck worth $207K as of Q2 2026.
  • GGM Financials bought 12 Merck shares in Q2 2026, an estimated $1.41K.
  • Merck made up 0.08% of GGM Financials's portfolio in Q2 2026, its #84 holding.
  • GGM Financials first reported a position in Merck in Q3 2024 and has held it in 5 quarters since.
  • GGM Financials's Merck position peaked at $233K in Q3 2024.
  • 1,170 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on GGM Financials's 13F filing for Q2 2026, filed 23 Jul 2026.